|
|
Registro Completo |
Biblioteca(s): |
Ebooks. |
Data corrente: |
15/08/2008 |
Data da última atualização: |
16/06/2011 |
Autoria: |
HURLEY, L. H. â. |
Afiliação: |
Laurence H. âed Hurley. |
Título: |
Advances in DNA sequence specific agents a research annual. |
Ano de publicação: |
1998 |
Fonte/Imprenta: |
London : Jai Press, 1998. |
Páginas: |
x, 283 p. |
Descrição Física: |
ill. ;23 cm. |
ISBN: |
9780762302031 |
Idioma: |
Inglês |
Conteúdo: |
Preface. Introduction to DNA Sequence-specific agents . Sequence-specific poisons of type II DNA topoisomerases. Topoisomerase I-targeting drugs: new developments in cancer pharmacology. DNA sequence recognition altered BIS-benzimidazole minor-groove binders. Sequence-specific recognition and modification of double-helical DNA by minor-groove binding conjugates structurally related to netropsin and distamycin. New developments in the use of nitrogen mustard alkylating agents as anticancer drugs. DNA binding of nonclassical platinum antitumor complexes. Kedarcidin and maduropeptin: two novel antitumor chromoproteins with selective protease activity and DNA cleaving properties. Antisense- and antigene-based drug design strategies in oncology. Sequence-specific recognition of double-stranded DNA by peptide nucleic acids.In this volume the entire focus is devoted to the macromolecule target specificity of DNA interactive developmental therapeutic agents of current interest. A brief introduction to DNA interactive anticancer agents is included for readers who may benefit from an overview surrounding the developments that have contributed to our general understanding of this field. The following nine chapters have been carefully chosen so that they describe topics which are at the forefront of development in DNA-targeted cancer chemotherapy. Issues that have been addressed include the mechanisms of selective DNA topoisomerase I and II poisoning by antitumor agents (Chapters 1 and 2), sequence-specific recognition of DNA by groove-binding drugs and drug-conjugates (Chapters 3 and 4), recent developments in nitrogen mustard alkylating agents and their potential use for antibody-directed enzyme-prodrug therapy (Chapter 5), nonclassical platinum anticancer complexes, including dinuclear and trans-platinum derivatives (Chapter 6), DNA cleaving antitumor chromoproteins containing reactive enediyne moieties, which exhibit interesting free-radical chemistry along with selective targeting (Chapter 7), the potential of new sequence-specific antisense and antigene therapy in oncology (Chapter 8), and finally the conceivable chemotherapeutic use of mimetics of the DNA structure, obtained by substitution of the sugar-phosphate natural chain with a peptide backbone, the so-called peptide nucleic acids (Chapter 9). Important approaches being currently investigated for selective cancer treatment, such as gene therapy and immunochemotherapy, are not discussed in this volume since they fall beyond its scope. MenosPreface. Introduction to DNA Sequence-specific agents . Sequence-specific poisons of type II DNA topoisomerases. Topoisomerase I-targeting drugs: new developments in cancer pharmacology. DNA sequence recognition altered BIS-benzimidazole minor-groove binders. Sequence-specific recognition and modification of double-helical DNA by minor-groove binding conjugates structurally related to netropsin and distamycin. New developments in the use of nitrogen mustard alkylating agents as anticancer drugs. DNA binding of nonclassical platinum antitumor complexes. Kedarcidin and maduropeptin: two novel antitumor chromoproteins with selective protease activity and DNA cleaving properties. Antisense- and antigene-based drug design strategies in oncology. Sequence-specific recognition of double-stranded DNA by peptide nucleic acids.In this volume the entire focus is devoted to the macromolecule target specificity of DNA interactive developmental therapeutic agents of current interest. A brief introduction to DNA interactive anticancer agents is included for readers who may benefit from an overview surrounding the developments that have contributed to our general understanding of this field. The following nine chapters have been carefully chosen so that they describe topics which are at the forefront of development in DNA-targeted cancer chemotherapy. Issues that have been addressed include the mechanisms of selective DNA topoisomerase I and II poisoning by antitumor agents (Chapters 1 and ... Mostrar Tudo |
Categoria do assunto: |
-- |
URL: |
https://www.sciencedirect.com/science/publication?issn=1067568X&volume=3
|
Marc: |
LEADER 02913nam a2200133 a 4500 001 1711158 005 2011-06-16 008 1998 bl uuuu u0uu1 u #d 020 $a9780762302031 100 1 $aHURLEY, L. H. â. 245 $aAdvances in DNA sequence specific agents a research annual.$h[electronic resource] 260 $aLondon : Jai Press$c1998 300 $ax, 283 p. $cill. ;23 cm. 520 $aPreface. Introduction to DNA Sequence-specific agents . Sequence-specific poisons of type II DNA topoisomerases. Topoisomerase I-targeting drugs: new developments in cancer pharmacology. DNA sequence recognition altered BIS-benzimidazole minor-groove binders. Sequence-specific recognition and modification of double-helical DNA by minor-groove binding conjugates structurally related to netropsin and distamycin. New developments in the use of nitrogen mustard alkylating agents as anticancer drugs. DNA binding of nonclassical platinum antitumor complexes. Kedarcidin and maduropeptin: two novel antitumor chromoproteins with selective protease activity and DNA cleaving properties. Antisense- and antigene-based drug design strategies in oncology. Sequence-specific recognition of double-stranded DNA by peptide nucleic acids.In this volume the entire focus is devoted to the macromolecule target specificity of DNA interactive developmental therapeutic agents of current interest. A brief introduction to DNA interactive anticancer agents is included for readers who may benefit from an overview surrounding the developments that have contributed to our general understanding of this field. The following nine chapters have been carefully chosen so that they describe topics which are at the forefront of development in DNA-targeted cancer chemotherapy. Issues that have been addressed include the mechanisms of selective DNA topoisomerase I and II poisoning by antitumor agents (Chapters 1 and 2), sequence-specific recognition of DNA by groove-binding drugs and drug-conjugates (Chapters 3 and 4), recent developments in nitrogen mustard alkylating agents and their potential use for antibody-directed enzyme-prodrug therapy (Chapter 5), nonclassical platinum anticancer complexes, including dinuclear and trans-platinum derivatives (Chapter 6), DNA cleaving antitumor chromoproteins containing reactive enediyne moieties, which exhibit interesting free-radical chemistry along with selective targeting (Chapter 7), the potential of new sequence-specific antisense and antigene therapy in oncology (Chapter 8), and finally the conceivable chemotherapeutic use of mimetics of the DNA structure, obtained by substitution of the sugar-phosphate natural chain with a peptide backbone, the so-called peptide nucleic acids (Chapter 9). Important approaches being currently investigated for selective cancer treatment, such as gene therapy and immunochemotherapy, are not discussed in this volume since they fall beyond its scope.
Download
Esconder MarcMostrar Marc Completo |
Registro original: |
Ebooks (Ebooks) |
|
Nenhum exemplar cadastrado para este documento. |
Voltar
|
|
Registros recuperados : 5.403 | |
4. | | SIDER, L. H. Biologia avançada na produção de pequenos ruminantes. In: CONGRESSO BRASILEIRO DE ZOOTECNIA, 18.; CONGRESSO INTERNACIONAL DE ZOOTECNIA, 10.; SIMPÓSIO PARAIBANO DE ZOOTECNIA, 6.; FORÚM DE COORDENADORES DE CURSOS DE ZOOTECNIA DAS UNIVERSIDADES BRASILEIRAS, 4.; FORÚM DE ESTUDANTES DE CURSOS DE ZOOTECNIA DAS UNIVERSIDADES BRASILEIRAS, 4.; REUNIÃO NACIONAL DE ENSINO DE ZOOTECNIA, 14.; FORÚM DE ENTIDADES DE ZOOTECNISTAS, 31.; MOSTRA DE RAÇAS DE CAPRINOS E OVINOS NATIVOS, 3.; SEMANA DA CAPRINOCULTURA E DA OVINOCULTURA BRASILEIRAS, 6., 2008, João Pessoa. Anais... João Pessoa: Associação Brasileira de Zootecnia: Embrapa Caprinos; UFPB, 2008. 10 f. 1 CD-ROM.Tipo: Artigo em Anais de Congresso |
Biblioteca(s): Embrapa Caprinos e Ovinos. |
| |
8. | | BASSOI, L. H. A agricultura irrigada na Região Nordeste. In: RODRIGUES, L. N.; DOMINGUES, A. F. (Ed.). Agricultura irrigada: desafios e oportunidades para o desenvolvimento sustentável. Brasília, DF: INOVAGRI, 2017. p. 235-236. Mesa 1: O estado da arte na Agricultura irrigada no Brasil. Palestra 4.Tipo: Resumo em Anais de Congresso |
Biblioteca(s): Embrapa Semiárido. |
| |
Registros recuperados : 5.403 | |
|
Nenhum registro encontrado para a expressão de busca informada. |
|
|